Logan Capital Management’s Idexx Laboratories IDXX Stock Holding History

Logan Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7	Closed	-$3.54K	–	551
2024 Q3	$3.54K	Hold	7	–	–	﹤0.01%	435
2024 Q2	$3.41K	Hold	7	–	–	﹤0.01%	422
2024 Q1	$3.78K	Hold	7	–	–	﹤0.01%	425
2023 Q4	$3.88K	Hold	7	–	–	﹤0.01%	441
2023 Q3	$3.06K	Hold	7	–	–	﹤0.01%	440
2023 Q2	$3.52K	Hold	7	–	–	﹤0.01%	429
2023 Q1	$3.5K	Hold	7	–	–	﹤0.01%	442
2022 Q4	$2.86K	Hold	7	–	–	﹤0.01%	480
2022 Q3	$2K	Hold	7	–	–	﹤0.01%	472
2022 Q2	$2K	Hold	7	–	–	﹤0.01%	502
2022 Q1	$4K	Hold	7	–	–	﹤0.01%	484
2021 Q4	$5K	Hold	7	–	–	﹤0.01%	495
2021 Q3	$4K	Hold	7	–	–	﹤0.01%	490
2021 Q2	$4K	Hold	7	–	–	﹤0.01%	483
2021 Q1	$3K	Buy	+7	New	+$3.51K	﹤0.01%	469

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Logan Capital Management's IDXX Position: Q4 2024 in Review

Logan Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 7 shares — an estimated $3.54K sold.

Logan Capital Management first reported a position in IDXX in Q1 2021 and held it in 15 quarters. The position peaked at $5K in Q4 2021. 1,125 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

Logan Capital Management reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
Logan Capital Management sold 7 Idexx Laboratories shares in Q4 2024, an estimated $3.54K.
Logan Capital Management first reported a position in Idexx Laboratories in Q1 2021 and held it in 15 quarters.
Logan Capital Management's Idexx Laboratories position peaked at $5K in Q4 2021.
1,125 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Logan Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.